Product Information
DOFETILIDE 250 MCG CAPSULE is a generic product labeled by Sigmapharm Laboratories LLC, priced at $0.1933 per EA under NDC 42794004510. Its NADAC has been published 407 times since Sep 12, 2018.
Strength
250 ug/1
Manufacturer
Sigmapharm Laboratories LLCNDC
42794004510
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOFETILIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207746On Market Since
6/11/2018
Pharmacological Classes
Price Statistics
The NADAC for DOFETILIDE 250 MCG CAPSULE has been published 407 times since Sep 12, 2018, and over the history we have for it it has declined 96.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1933 per EA |
|---|---|
| All-time high | $4.9785 (Sep 12, 2018) |
| All-time low | $0.1886 (Feb 18, 2026) |
| 52-week high | $0.2231 |
| 52-week low | $0.1886 |
| Median price | $0.7762 |
| Average price | $1.1843 |
| Largest weekly change | +51.6% (Aug 17, 2022) |
| Weeks tracked | 407 |
| Tracking since | Sep 12, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Dofetilide market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of DOFETILIDE 250 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for DOFETILIDE 250 MCG CAPSULE, manufactured by Sigmapharm Laboratories LLC, is $0.1933 per EA (NDC 42794004510), effective Jun 24, 2026.
How has the price of DOFETILIDE 250 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for DOFETILIDE 250 MCG CAPSULE has declined 96.1%. It has been tracked across 407 weekly CMS publications since Sep 12, 2018.
What are the highest and lowest recorded NADAC prices for DOFETILIDE 250 MCG CAPSULE?
Since Sep 12, 2018, the NADAC for DOFETILIDE 250 MCG CAPSULE has ranged from a low of $0.1886 (Feb 18, 2026) to a high of $4.9785 (Sep 12, 2018), with a median of $0.7762 per EA.
Are there cheaper alternatives to DOFETILIDE 250 MCG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DOFETILIDE 250 MCG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures DOFETILIDE 250 MCG CAPSULE?
DOFETILIDE 250 MCG CAPSULE (NDC 42794004510) is labeled by Sigmapharm Laboratories LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification